Home Healthcare IT Neurovascular Devices Market Size, Top Share, Forecast to 2033

Neurovascular Devices Market Size, Share & Trends Analysis Report By Product (Embolization Devices, Revascularization Devices Inactivated Vaccines, Thrombectomy Devices, Embolic Protection Devices, Accessory Devices), By Disease Pathology (Aneurysm, Arteriovenous Malformation and Fistulas (AVM), Ischemic Stroke, Stenosis, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRHI54276DR
Last Updated: May, 2025
Pages: 110
Author: Debashree Bora
Format: PDF, Excel

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Neurovascular Devices Market Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Embolization Devices
        1. By Value
      3. Revascularization Devices Inactivated Vaccines
        1. By Value
      4. Thrombectomy Devices
        1. By Value
      5. Embolic Protection Devices
        1. By Value
      6. Accessory Devices
        1. By Value
    3. By Disease Pathology
      1. Introduction
        1. Disease Pathology By Value
      2. Aneurysm
        1. By Value
      3. Arteriovenous Malformation and Fistulas (AVM)
        1. By Value
      4. Ischemic Stroke
        1. By Value
      5. Stenosis
        1. By Value
      6. Others
        1. By Value
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Embolization Devices
        1. By Value
      3. Revascularization Devices Inactivated Vaccines
        1. By Value
      4. Thrombectomy Devices
        1. By Value
      5. Embolic Protection Devices
        1. By Value
      6. Accessory Devices
        1. By Value
    3. By Disease Pathology
      1. Introduction
        1. Disease Pathology By Value
      2. Aneurysm
        1. By Value
      3. Arteriovenous Malformation and Fistulas (AVM)
        1. By Value
      4. Ischemic Stroke
        1. By Value
      5. Stenosis
        1. By Value
      6. Others
        1. By Value
    4. U.S.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Embolization Devices
          1. By Value
        3. Revascularization Devices Inactivated Vaccines
          1. By Value
        4. Thrombectomy Devices
          1. By Value
        5. Embolic Protection Devices
          1. By Value
        6. Accessory Devices
          1. By Value
      2. By Disease Pathology
        1. Introduction
          1. Disease Pathology By Value
        2. Aneurysm
          1. By Value
        3. Arteriovenous Malformation and Fistulas (AVM)
          1. By Value
        4. Ischemic Stroke
          1. By Value
        5. Stenosis
          1. By Value
        6. Others
          1. By Value
    5. Canada
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Embolization Devices
        1. By Value
      3. Revascularization Devices Inactivated Vaccines
        1. By Value
      4. Thrombectomy Devices
        1. By Value
      5. Embolic Protection Devices
        1. By Value
      6. Accessory Devices
        1. By Value
    3. By Disease Pathology
      1. Introduction
        1. Disease Pathology By Value
      2. Aneurysm
        1. By Value
      3. Arteriovenous Malformation and Fistulas (AVM)
        1. By Value
      4. Ischemic Stroke
        1. By Value
      5. Stenosis
        1. By Value
      6. Others
        1. By Value
    4. U.K.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Embolization Devices
          1. By Value
        3. Revascularization Devices Inactivated Vaccines
          1. By Value
        4. Thrombectomy Devices
          1. By Value
        5. Embolic Protection Devices
          1. By Value
        6. Accessory Devices
          1. By Value
      2. By Disease Pathology
        1. Introduction
          1. Disease Pathology By Value
        2. Aneurysm
          1. By Value
        3. Arteriovenous Malformation and Fistulas (AVM)
          1. By Value
        4. Ischemic Stroke
          1. By Value
        5. Stenosis
          1. By Value
        6. Others
          1. By Value
    5. Germany
    6. France
    7. Spain
    8. Italy
    9. Russia
    10. Nordic
    11. Benelux
    12. Rest of Europe
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Embolization Devices
        1. By Value
      3. Revascularization Devices Inactivated Vaccines
        1. By Value
      4. Thrombectomy Devices
        1. By Value
      5. Embolic Protection Devices
        1. By Value
      6. Accessory Devices
        1. By Value
    3. By Disease Pathology
      1. Introduction
        1. Disease Pathology By Value
      2. Aneurysm
        1. By Value
      3. Arteriovenous Malformation and Fistulas (AVM)
        1. By Value
      4. Ischemic Stroke
        1. By Value
      5. Stenosis
        1. By Value
      6. Others
        1. By Value
    4. China
      1. By Product
        1. Introduction
          1. Product By Value
        2. Embolization Devices
          1. By Value
        3. Revascularization Devices Inactivated Vaccines
          1. By Value
        4. Thrombectomy Devices
          1. By Value
        5. Embolic Protection Devices
          1. By Value
        6. Accessory Devices
          1. By Value
      2. By Disease Pathology
        1. Introduction
          1. Disease Pathology By Value
        2. Aneurysm
          1. By Value
        3. Arteriovenous Malformation and Fistulas (AVM)
          1. By Value
        4. Ischemic Stroke
          1. By Value
        5. Stenosis
          1. By Value
        6. Others
          1. By Value
    5. Korea
    6. Japan
    7. India
    8. Australia
    9. Taiwan
    10. South East Asia
    11. Rest of Asia-Pacific
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Embolization Devices
        1. By Value
      3. Revascularization Devices Inactivated Vaccines
        1. By Value
      4. Thrombectomy Devices
        1. By Value
      5. Embolic Protection Devices
        1. By Value
      6. Accessory Devices
        1. By Value
    3. By Disease Pathology
      1. Introduction
        1. Disease Pathology By Value
      2. Aneurysm
        1. By Value
      3. Arteriovenous Malformation and Fistulas (AVM)
        1. By Value
      4. Ischemic Stroke
        1. By Value
      5. Stenosis
        1. By Value
      6. Others
        1. By Value
    4. UAE
      1. By Product
        1. Introduction
          1. Product By Value
        2. Embolization Devices
          1. By Value
        3. Revascularization Devices Inactivated Vaccines
          1. By Value
        4. Thrombectomy Devices
          1. By Value
        5. Embolic Protection Devices
          1. By Value
        6. Accessory Devices
          1. By Value
      2. By Disease Pathology
        1. Introduction
          1. Disease Pathology By Value
        2. Aneurysm
          1. By Value
        3. Arteriovenous Malformation and Fistulas (AVM)
          1. By Value
        4. Ischemic Stroke
          1. By Value
        5. Stenosis
          1. By Value
        6. Others
          1. By Value
    5. Turkey
    6. Saudi Arabia
    7. South Africa
    8. Egypt
    9. Nigeria
    10. Rest of MEA
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Embolization Devices
        1. By Value
      3. Revascularization Devices Inactivated Vaccines
        1. By Value
      4. Thrombectomy Devices
        1. By Value
      5. Embolic Protection Devices
        1. By Value
      6. Accessory Devices
        1. By Value
    3. By Disease Pathology
      1. Introduction
        1. Disease Pathology By Value
      2. Aneurysm
        1. By Value
      3. Arteriovenous Malformation and Fistulas (AVM)
        1. By Value
      4. Ischemic Stroke
        1. By Value
      5. Stenosis
        1. By Value
      6. Others
        1. By Value
    4. Brazil
      1. By Product
        1. Introduction
          1. Product By Value
        2. Embolization Devices
          1. By Value
        3. Revascularization Devices Inactivated Vaccines
          1. By Value
        4. Thrombectomy Devices
          1. By Value
        5. Embolic Protection Devices
          1. By Value
        6. Accessory Devices
          1. By Value
      2. By Disease Pathology
        1. Introduction
          1. Disease Pathology By Value
        2. Aneurysm
          1. By Value
        3. Arteriovenous Malformation and Fistulas (AVM)
          1. By Value
        4. Ischemic Stroke
          1. By Value
        5. Stenosis
          1. By Value
        6. Others
          1. By Value
    5. Mexico
    6. Argentina
    7. Chile
    8. Colombia
    9. Rest of LATAM
    1. Neurovascular Devices Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. B. Braun Melsungen AG
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Integer Holdings Corporation
    3. Johnson & Johnson
    4. Microport Scientific Corporation
    5. Penumbra, INC.
    6. Phenox GmbH
    7. Stryker Corporation
    8. Terumo Corporation
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer
Get This Report

Download Free Sample

Our Clients:

LG Electronics
AMCAD Engineering
KOBE STEEL LTD.
Hindustan National Glass & Industries Limited
Voith Group
International Paper
Hansol Paper
Whirlpool Corporation
Sony
Samsung Electronics
Qualcomm
Google
Fiserv
Veto-Pharma
Nippon Becton Dickinson
Merck
Argon Medical Devices
Abbott
Ajinomoto
Denon
Doosan
Meiji Seika Kaisha Ltd
LG Chemicals
LCY chemical group
Bayer
Airrane
BASF
Toyota Industries
Nissan Motors
Neenah
Mitsubishi
Hyundai Motor Company

We are featured on:

WhatsApp
Chat with us on WhatsApp
Address:
Office 515 A, Amanora Chambers,
Amanora Park Town, Hadapsar,
Pune 411028, Maharashtra, India.
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
DMCA.com Protection Status
Secure Payments:
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.